Get MindMed Updates:
We help patients unlock the healing power of the mind through Psychedelic Inspired Medicines & Experiential Therapies.
Together we can overcome.
Get MindMed Updates:
We help patients unlock the healing power of the mind through Psychedelic Inspired Medicines & Experiential Therapies.
Together we can overcome.
MindMed Announces Initiation of Phase 1 Clinical Trial of Intravenous DMT
Solving for mental illness and addiction requires a novel approach
Transcending traditional mental healthcare to treat Anxiety
Unlocking a new kind of healing for ADHD & Addiction
Developing new compounds, therapies, methods and technologies to optimize patient outcomes
CLINICAL TRIALS
PRE-DISCOVERY
DISCOVERY
PRE-CLINICAL
PHASE 1
PHASE 2A
PHASE 2B
PHASE 3
18-MC
Substance Use Disorders
Substance Use Disorders
PHASE 2A
LSD Microdosing
Adult ADHD
Adult ADHD
PHASE 2A
University Hospital Basel
LSD Assisted Therapy
Cluster Headaches
Multiple Ongoing or Completed: on LSD, MDMA, DMT, Psilocybin
LSD Assisted Therapy
PHASE 2
Cluster Headaches
PHASE 2
Multiple Ongoing or Completed: on LSD, MDMA, DMT, Psilocybin
PHASE 1
Patients and therapists deserve care that transcends traditional symptom management cycles, advancing long-term mental healing.
View our approachRigorous science of novel psychedelic compounds, therapies, and healing technologies in collaboration with leading institutions and researchers to make faster discoveries, together
Conducting clinical trials of psychedelic inspired medicines and experiential therapies within existing regulatory pathways to ensure the most effective & transformative healing experience possible
We hold ourselves and our products to the highest levels of safety, efficacy, and accessibility so psychedelic inspired medicines and experiential therapies can one day reach patients in need
Partnerships
Partnerships
Partnerships
Press Release
Press Release
Press Release
Press Release
Press Release
IN THE PRESS
This could save lives, cure depression, help alcoholism, get people off opioids—why wouldn’t I want to be invested?”
MindMed named one of 36 startups that could change the world
MindMed could have the key to providing the upsides of psychedelic drugs for both focus and addiction treatment—while cutting out the downsides of tripping.”
Our interdisciplinary team of drug development veterans, savvy technologists, and mental health experts was purpose-built to tackle these challenges. With over a century of combined experience in product development and commercialization, we have the know-how and the heart to introduce a better approach to mental health.
MEET MINDMED
